Total returns on $1000
1Y
- 3M
- 6M
- 1Y
- 3Y
- 5Y
Fund/benchmark | Change | |
---|---|---|
Price | RTW Biotech Opportunities Ltd (Ordinary Share) | +12.10% |
NAV | RTW Biotech Opportunities Ltd (Ordinary Share) | +4.14% |
Morningstar's Benchmark | (Russell 2000 Biotech Growth) 50.000% + ( Nasdaq Biotechnology Index) 50.000% | -- |
Key statistics
On Thursday, RTW Biotech Opportunities Ltd (RTW:LSE) closed at 1.43, -1.23% below its 52-week high of 1.44, set on May 28, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Shares outstanding | 336.11m |
---|---|
Market cap | 466.64m USD |
Total assets | 590.86m USD |
Total expense ratio | 1.97% |
High | 1.40 |
Low | 1.39 |
Previous close | 1.39 |
Average volume | 259.72k |
---|---|
YTD Change | +1.60% |
Beta | 0.6281 |
Diluted NAV (est) | 1.76 |
Diluted NAV (last pub) | 1.76 |
Premium/Discount | -19.74% |
Net Gearing | 0.00% |
Data delayed at least 20 minutes, as of Jun 06 2024 16:04 BST.
More ▼